The multi‐target inhibition of two significant cancer drug targets, cathepsin B and human carbonic anhydrase (hCA) isoforms IX and XII has been explored. The exclusive synthesis of single isomeric structure of final compounds despite two possibilities, in vitro biological studies, in silico molecular docking, DFT and A...
Lalit Vats, Manishita Rani, Kiran Siwach et al.· Archiv der Pharmazie· 0 citations
The first biochemical and functional characterization of β‐class carbonic anhydrase from Bifidobacterium longum (BloCAβ) by inhibition and activation profiles is reported, establishing a biochemical basis for future studies investigating the physiological role of probiotic CAs in bacterial models.
Simone Giovannuzzi, Andrea Ammara, Simone Carradori et al.· Archiv der Pharmazie· 0 citations
A series of alkyl coumarin-tethered phenyl quinazolinones were rationally designed and synthesized as hypoxia-targeted dual hCA IX/HSP90α inhibitors, exhibiting potent, highly selective inhibition of hCA IX (in the nanomolar range), while displaying negligible activity against the off-target isoforms hCA I and II.
Amal S. Elgohary, Mervat H. El-Hamamsy, N. Sharafeldin et al.· RSC Advances· 0 citations
Human carbonic anhydrases (hCAs) are zinc‐bound enzymes that play a critical role in pH regulation and ion balance. Among them, isoforms hCA IX and XII are overexpressed in tumor hypoxia and are implicated in tumor progression. In this study, new indole‐benzenesulfonamide derivatives with hydrazide and amide linkers we...
V. Manasa, Sabesan Jayaprakash, Niccolò Paoletti et al.· ChemMedChem· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.